Medicure
Receives $14.6 Million From Exercise of Common Share Purchase Warrants
December 24, 2003
Medicure
Receives FDA & TPD Approval for Phase II Clinical Trial
of MC-1 for Treatment of Coronary Bypass Surgery
November 20, 2003
Medicure
Strengthens Proprietary Position With Receipt of Eighth USA Patent
in the Treatment of Cardiovascular and Related Diseases
November 12, 2003
Medicure
Announces First Quarter Financial Results
October 23, 2003
Medicure
Files For Approval Of Phase II Clinical Trial Of MC-1 In CABG
October 15, 2003
Medicure
to Conduct Web Cast of Annual General and
Special Meeting of Shareholders
October 9, 2003
Medicure
Appoints Moray Merchant Vice-President, Market Development
October 7, 2003
Results
From Medicure's MEND-1, Phase II Clinical Trial Presented at Prestigious
TCT Conference in Washington
September 26, 2003
Results
From Medicure's MEND-1 Trial Published in
American Journal of Cardiology
September 23, 2003
Medicure
Announces Fiscal 2003 Financial Results
August 27, 2003
Medicure
Fortifies Proprietary Position With Receipt Of Its First Patent
In The Treatment Of Stroke
August 11, 2003
Medicure
Commences Initial Phase II/III Hypertension Trial
July 23, 2003
Medicure
Strengthens Management Team with Appointment of Dr. Ahmad Khalil
as Director of Scientific Affairs
July 9, 2003
Medicure
Closes $7.6 Million Private Placement
June 26, 2003
Medicure
Announces Private Placement of Approximately $7.0 Million
June 13, 2003
Medicure
Appoints Dr. Robert Burford as Vice President, Product Development
June 9, 2003
Medicure
Announces Second Clinical Candidate And Phase II/III Program
June 4, 2003
Medicure
Accepted to Present at Prestigious BIO 2003 Convention in Washington,
D.C.
June 2, 2003
Medicure
to Present at BioFinance 2003
May 1, 2003
Medicure's
Announces Third Quarter/Nine Month Financial Results
April 24, 2003
Medicure's
Drug Discovery Program Strengthened With Issuance Of New US Patent
Allowances
April 3, 2003
Medicure,
Duke Spotlight MEND-1 Results at Satellite Session of the American
College of Cardiology Meetings
March 31, 2003
Medicure,
Duke Spotlight MEND-1 Results at the American College of Cardiology
Meetings
March 28, 2003
Medicure
To Present At Wall Street Transcript's "Investing In Healthcare"
Conference
March 20, 2003
Medicure
Announces Conversion of Class A Common Shares
February 26, 2003
Medicure Celebrate Phase II Results
With Winnipeg Investment Community
January 31, 2003
Medicure Announces Second Quarter/Six
Month Financial Results
January 29, 2003
Medicure Announces Positive Results
From Phase II Trial On MC-1
January 14, 2003
Medicure Hires Investor Relations
Professional, Unveils Enhanced Corporate Website
January 10, 2003
Medicure To Host Conference Call
On Phase II Clinical Study Results
January 9, 2003
Back to Latest News
